PLA2G7 and urinary bladder cancer: To elucidate the mechanisms underlying PLA2G7 overexpression in bladder cancer, we initially examined genomic alterations, including copy number variations (CNVs) and methylation status of PLA2G7 within TCGA bladder cancer data.